Systemic Brain Delivery of Oligonucleotide Therapeutics Enhanced by Protein Corona-Assisted DNA Cubes

Authors
Kim, Kyoung-RanKang, Ji HeeThai, Hien Bao DieuBack, Ji HyunMao, ChengdeLee, Ji EunKo, Young TagAhn, Dae-Ro
Issue Date
2025-06
Publisher
WILEY-V C H VERLAG GMBH
Citation
Small Methods, v.9, no.6
Abstract
The systemic delivery of oligonucleotide therapeutics to the brain is challenging but highly desirable for the treatment of brain diseases undruggable with traditional small-molecule drugs. In this study, a set of DNA nanostructures is prepared and screened them to develop a protein corona-assisted platform for the brain delivery of oligonucleotide therapeutics. The biodistribution analysis of intravenously injected DNA nanostructures reveals that a cube-shaped DNA nanostructure (D-Cb) can penetrate the brain-blood barrier (BBB) and reach the brain tissue. The brain distribution level of D-Cb is comparable to that of other previous nanoparticles conjugated with brain-targeting ligands. Proteomic analysis of the protein corona formed on D-Cb suggests that its brain distribution is driven by endothelial receptor-targeting ligands in the protein corona, which mediate transcytosis for crossing the BBB. D-Cb is subsequently used to deliver an antisense oligonucleotide (ASO) to treat glioblastoma multiforme (GBM) in mice. While free ASO is unable to reach the brain, ASO loaded onto D-Cb is delivered efficiently to the brain tumor region, where it downregulates the target gene and exerts an anti-tumor effect on GBM. D-Cb is expected to serve as a viable platform based on protein corona formation for systemic brain delivery of oligonucleotide therapeutics. In vivo, screening of DNA nanostructures yields a cube-shaped structure (D-Cb) as a protein corona-assisted platform for brain delivery of oligonucleotide therapeutics. D-Cb effectively delivers polo-like kinase 1 (PLK-1) antisense oligonucleotides (ASO) to treat glioblastoma in an orthotopic mouse model, demonstrating its potential as a carrier for brain-targeted gene therapy. image
Keywords
NANOPARTICLES; MECHANISMS; RECEPTORS; TRANSPORT; BARRIER; glioblastoma multiforme; oligonucleotide therapeutics; protein corona; DNA nanostructures; brain delivery
ISSN
2366-9608
URI
https://pubs.kist.re.kr/handle/201004/150451
DOI
10.1002/smtd.202400902
Appears in Collections:
KIST Article > 2024
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE